Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy
about
Automated drug screening with contractile muscle tissue engineered from dystrophic myoblastsInvestigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophySildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiencyRecent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trialsMitochondrial Regulation of the Muscle Microenvironment in Critical Limb IschemiaDasatinib as a treatment for Duchenne muscular dystrophyNutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the ConjectureTreatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophyRecent advances using zebrafish animal models for muscle disease drug discoveryFunctional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout miceVasodilation of intramuscular arterioles under shear stress in dystrophin-deficient skeletal muscle is impaired through decreased nNOS expression.Drug screening in a zebrafish model of Duchenne muscular dystrophy.PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish.One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler development.Zebrafish based small molecule screens for novel DMD drugs.Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice.Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling.Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters.Anesthesia with Disuse Leads to Autophagy Up-regulation in the Skeletal MuscleHooked! Modeling human disease in zebrafish.Nonmechanical Roles of Dystrophin and Associated Proteins in Exercise, Neuromuscular Junctions, and Brains.A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.Emerging drugs for Duchenne muscular dystrophyAbsence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibitionMolecular dissection of dystrophin identifies the docking site for nNOSBacterial-excreted small volatile molecule 2-aminoacetophenone induces oxidative stress and apoptosis in murine skeletal muscle.Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.Alternative mechanism for white adipose tissue lipolysis after thermal injury.Vascular-targeted therapies for Duchenne muscular dystrophyNovel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agentsSarcolemma-localized nNOS is required to maintain activity after mild exerciseInhibition of prostaglandin D synthase suppresses muscular necrosis.Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin-Deficient Hearts.Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.Muscle-specific AMPK β1β2-null mice display a myopathy due to loss of capillary density in nonpostural muscles.Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of duchenne muscular dystrophy.Respiratory diseases and muscle dysfunction.
P2860
Q24629251-54777B6E-5C13-4568-9B28-90205EFE488DQ24644090-E991E9DF-3E10-49C4-B1BA-5A244383FED1Q24655371-B354038E-CB16-4D7B-AEAA-E15F5319A855Q26741409-9460A4E4-5703-481B-B747-A6487F6A2299Q26774784-DB788597-A994-4CFD-859F-DC7428F92D99Q27300846-39180391-8C9A-46E2-A635-98E6EC76DE1DQ28072269-EB3C383A-DEDF-41D3-B444-4D8B3BBDD67AQ28484851-0CA238F1-BE63-4FDF-A129-095E42D145C4Q28551915-E26B9D0C-781F-41FB-884D-95B330916B8DQ33375717-7F2A8598-6BFF-4635-A493-BF0A1B8C021DQ33810293-0B9AA7E4-9360-4579-A2EA-25148D2B3214Q33845739-C335FF37-911E-4C68-A341-945DDB26AF40Q33987140-68237A55-25AE-4530-8909-51DEB4E6B1ECQ34087155-3FF8C603-EBCE-452B-8428-2BBF304EA40DQ34341005-6CE331B2-18F5-4F8C-85CC-F4C8E35E0E9BQ34706642-2252A1B8-95DC-4F74-A3EE-AAAAB20C1F8EQ34764061-71EF5CB2-D3DD-4F9D-8CB2-8E4D3D44CEFBQ35043351-87440418-800A-4D65-BBC7-AC5A188EB011Q35195095-89DC9AA6-264A-45BE-A543-DBF8F7D5B001Q35629979-046798E3-E32A-40F3-B283-0184DAEF836BQ36068284-2A60AAEF-2A21-473F-9CAA-50CD24537879Q36105739-43BBC210-C022-44FC-962B-BCCA0B201735Q36179162-85657B54-2AEF-4215-BFEC-C0707D0FEC58Q36363716-C3D28CED-B7B9-48A1-AB2E-C86902961AEBQ36422465-145C48BD-A4EA-439F-B176-297B81AED385Q36467072-7681C54C-6FA1-4BE2-AF84-26BE3FACED44Q36535281-D8664744-0AC0-41C3-8F40-950BB3EB32CCQ36684324-EFDDE504-6424-4B26-94D2-3CA77DCA0EDEQ36703021-61A8614D-935F-495A-9D49-5946F0872CBCQ36757998-ABC1D81F-2043-46D1-8A81-8DDE0C924837Q36835180-B03C0AD4-8E27-4B6C-844D-D3EF5441FC09Q36925191-DF9D3635-D33D-4ABD-AF18-912FDD57E81EQ36987100-BC1DFC5A-0FE8-4CA4-9607-D09AACD14727Q37164193-7761BD61-A500-4053-B551-D446834016D4Q37240478-C02294EF-9E7F-49D7-9F34-CFB94E93E865Q37601041-1F76B1C9-78C5-449C-B395-33C480C7939FQ37604365-E5E51FC5-0E1F-475C-806A-A680A2524A14Q37702924-13BF6565-510D-43FC-BD2A-F80D84ED82A1Q37893076-976C999C-8722-4EAE-AF3A-E74ECC0884E4Q37979250-B3981406-54B8-45EE-8257-1330243F0059
P2860
Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Primary role of functional isc ...... py in mouse muscular dystrophy
@ast
Primary role of functional isc ...... py in mouse muscular dystrophy
@en
Primary role of functional isc ...... py in mouse muscular dystrophy
@nl
type
label
Primary role of functional isc ...... py in mouse muscular dystrophy
@ast
Primary role of functional isc ...... py in mouse muscular dystrophy
@en
Primary role of functional isc ...... py in mouse muscular dystrophy
@nl
prefLabel
Primary role of functional isc ...... py in mouse muscular dystrophy
@ast
Primary role of functional isc ...... py in mouse muscular dystrophy
@en
Primary role of functional isc ...... py in mouse muscular dystrophy
@nl
P2093
P2860
P3181
P1433
P1476
Primary role of functional isc ...... py in mouse muscular dystrophy
@en
P2093
J A Jeevendra Martyn
Masao Kaneki
Nita Sahani
Shingo Egusa Yasuhara
Yasuyoshi Ouchi
P2860
P3181
P356
10.1371/JOURNAL.PONE.0000806
P407
P50
P577
2007-01-01T00:00:00Z